Lahorewala, S.; Panda, C.S.; Aguilar, K.; Morera, D.S.; Zhu, H.; Gramer, A.L.; Bhuiyan, T.; Nair, M.; Barrett, A.; Bollag, R.J.;
et al. Novel Molecular Signatures Selectively Predict Clinical Outcomes in Colon Cancer. Cancers 2025, 17, 919.
https://doi.org/10.3390/cancers17060919
AMA Style
Lahorewala S, Panda CS, Aguilar K, Morera DS, Zhu H, Gramer AL, Bhuiyan T, Nair M, Barrett A, Bollag RJ,
et al. Novel Molecular Signatures Selectively Predict Clinical Outcomes in Colon Cancer. Cancers. 2025; 17(6):919.
https://doi.org/10.3390/cancers17060919
Chicago/Turabian Style
Lahorewala, Sarrah, Chandramukhi S. Panda, Karina Aguilar, Daley S. Morera, Huabin Zhu, Adriana L. Gramer, Tawhid Bhuiyan, Meera Nair, Amanda Barrett, Roni J. Bollag,
and et al. 2025. "Novel Molecular Signatures Selectively Predict Clinical Outcomes in Colon Cancer" Cancers 17, no. 6: 919.
https://doi.org/10.3390/cancers17060919
APA Style
Lahorewala, S., Panda, C. S., Aguilar, K., Morera, D. S., Zhu, H., Gramer, A. L., Bhuiyan, T., Nair, M., Barrett, A., Bollag, R. J., & Lokeshwar, V. B.
(2025). Novel Molecular Signatures Selectively Predict Clinical Outcomes in Colon Cancer. Cancers, 17(6), 919.
https://doi.org/10.3390/cancers17060919